Exact Mass: 428.0540702
Exact Mass Matches: 428.0540702
Found 117 metabolites which its exact mass value is equals to given mass value 428.0540702,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
IDP
An inosine nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety. [HMDB] IDP is an inosine nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety. Acquisition and generation of the data is financially supported in part by CREST/JST.
fosfestrol
L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02A - Hormones and related agents > L02AA - Estrogens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D000970 - Antineoplastic Agents
Eltanexor
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor
Theaflavic acid
Epitheaflavic acid is found in tea. Epitheaflavic acid is isolated from black tea Camellia sinensis. Isolated from black tea Camellia sinensis. Epitheaflavic acid is found in tea.
3-Chloro-2-methyl-N-(4-(2-(4-methylpiperazin-1-yl)-2-oxoethyl)thiazol-2-yl)benzenesulfonamide
C17H21ClN4O3S2 (428.07435460000005)
(E)-4,4'-(Hex-3-ene-3,4-diyl)bis(4,1-phenylene) bis(dihydrogen phosphate)
[4-[4-(4-Hydroxyphenyl)hex-3-en-3-yl]phenyl] phosphono hydrogen phosphate
O1-Cinnamoyl-3-[3,5-bis(trifluoromethyl)phenyl]prop-2-enehydroximamide
PRZ_M429
C15H19Cl3N2O4S (428.0131064000001)
CONFIDENCE Transformation product, tentative ID (Level 2b); INTERNAL_ID 2009
L-Galacturonic acid calcium salt
C12H20CaO14+2 (428.04789300000004)
4-(3,4-Dihydroxyphenyl)-6,7-dihydroxynaphthalene-2-carboxylic acid 1,2-dicarboxyethyl ester
7-O-beta-D-(6-O-malonyl)glucopyranosyl-5-methoxy-1(3H)-isobenzofuranone
C18H20O12 (428.09547200000003)
(-)-3-hydroxy-N-methylwelwitindolinone C isothiocyanate|3-hydroxy-N-methylwelwitindolinone C isothiocyanate
SMZ-Pt
CONFIDENCE Probable structure via diagnostic evidence, tentative identification (Level 2b); ALGAE_TP_ID 3102
Cys Cys Cys Thr
Cys Cys Thr Cys
Cys Thr Cys Cys
2H-1-Benzopyran-2-one, 6-(1,2-dihydroxyethyl)-7-hydroxy-8-methoxy- glucuronide
C18H20O12 (428.09547200000003)
Thr Cys Cys Cys
Theaflavic acid
Melarsomine
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent
Methyl 4-acetoxy-7-(benzyloxy)-8-bromo-2-naphthoate
(1-Carboxyethyl)-triphenylphosphonium bromide methyl ester
4,4-[1,4-Phenylenebis(oxy)]bis[3-(trifluoromethyl)aniline]
(Carbethoxymethyl-1,2-13C2)triphenylphosphonium bromide
Ticarcillin sodium
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
4-N-OCTYLOXYBENZOIC ACID 2,4,5-TRICHLOROPHENYL ESTER
((1,3-Dioxolan-2-yl)methyl)triphenylphosphonium bromide
N-[4-[4-(benzylideneamino)-3-chlorophenyl]-2-chlorophenyl]-1-phenylmethanimine
C26H18Cl2N2 (428.08469679999996)
(Dimethylamino)dimethyl(2,3,4,5,6-pentafluorophenoxy)methanaminium hexafluorophosphate
C11H12F11N2OP (428.05115639999997)
N-[2-(4-oxo-3,1-benzoxazin-2-yl)phenyl]naphthalene-2-sulfonamide
C24H16N2O4S (428.08307360000003)
ethyl 1-(4-bromophenyl)-6,8-dimethoxypyrazolo[4,5,1-hi]indole-5-carboxylate
1-Boc-4-(3-Iodo-1H-indazol-4-yl)piperazine
C16H21IN4O2 (428.07091959999997)
Ferrate(3-), trisethanedioato(2-)-.kappa.O1,.kappa.O2-, triammonium, trihydrate, (OC-6-11)-
C6FeO12.3(NH4).3(H2O) (428.00872880000003)
2,2-(3-Bromo-4-methylthiophene-2,5-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
C17H27B2BrO4S (428.09994220000004)
tert-Butyl 4-(3-iodo-1H-indazol-6-yl)piperazine-1-carboxylate
C16H21IN4O2 (428.07091959999997)
1-[(Triisopropylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one
1-(4-nitrophenoxy)-2-[2-(4-nitrophenoxy)phenyl]benzene
Uprosertib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C155764 - AKT Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Uprosertib (GSK2141795) is a potent and selective pan-Akt inhibitor with IC50 values of 180/328/38 nM for Akt1/Akt2/Akt3, respectively.
N-(4-hydroxyphenyl)-4-[(5Z)-5-[(4-methoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanamide
C21H20N2O4S2 (428.08644400000003)
4-[[Glutamic acid]-carbonyl]-benzene-sulfonyl-d-proline
C17H20N2O9S (428.0889470000001)
Methyl 4-Bromo-N-[8-(Hydroxyamino)-8-Oxooctanoyl]-L-Phenylalaninate
S-{propyl[2-(2,4,6-trichlorophenoxy)ethyl]carbamoyl}cysteine
C15H19Cl3N2O4S (428.0131064000001)
3,4,5-trihydroxy-6-oxo-1-(3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl)benzo[7]annulene-8-carboxylic acid
[({[(2R,3S,4R)-3,4-dihydroxy-5-(6-oxo-6,9-dihydro-3H-purin-9-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid
[4-[4-(4-Hydroxyphenyl)hex-3-en-3-yl]phenyl] phosphono hydrogen phosphate
4-{[(1,3-diphenyl-1H-pyrazol-4-yl)methylene]amino}-5-(2-thienyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione
C22H16N6S2 (428.08778159999997)
1-Amino-4-(4-chloroanilino)-9,10-dioxo-2-anthracenesulfonic acid
C20H13ClN2O5S (428.0233678000001)
N-[4-(4-methyl-2-thiazolyl)-2-phenyl-3-pyrazolyl]-3-(trifluoromethyl)benzamide
2-(4-bromophenyl)-2-hydroxy-1-[4-(1H-indazol-5-ylamino)-1-piperidinyl]ethanone
ethyl 2-[(1-ethylbenzimidazol-2-yl)sulfanylmethyl]-5-methyl-4-oxo-3H-thieno[2,3-d]pyrimidine-6-carboxylate
C20H20N4O3S2 (428.09767700000003)
N-(3,5-dichloro-2-pyridinyl)-2-[(1-phenyl-2-benzimidazolyl)thio]acetamide
4-(3,5-Dimethyl-1-pyrazolyl)benzoic acid [2-(4-chloro-2-nitroanilino)-2-oxoethyl] ester
N-(4-bromo-2-methylphenyl)-4-[(1-methyl-2-oxo-4-quinolinyl)oxy]butanamide
2-[(3-acetyl-5-oxo-4H-imidazol-2-yl)thio]-N-(4-methyl-5-phenyl-2-thiazolyl)-N-prop-2-enylacetamide
C20H20N4O3S2 (428.09767700000003)
N-cyclopropyl-N-[2-[(4-methoxyphenyl)methylamino]-2-oxo-1-thiophen-2-ylethyl]-4-thiadiazolecarboxamide
C20H20N4O3S2 (428.09767700000003)
3-(4-oxo-1H-quinazolin-2-yl)propanoic acid [1-(4-bromophenyl)-1-oxopropan-2-yl] ester
Chrome fast yellow 8GL (acid form)
C19H12N2O8S (428.03143520000003)
[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 3-isocyanopropanoate
C14H17N6O8P (428.08454520000004)
4,5-dihydroxy-6-{[5-hydroxy-3-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy}-5,6-dihydro-4h-pyran-2-carboxylic acid
2-[4-(3,4-dihydroxyphenyl)-6,7-dihydroxynaphthalene-2-carbonyloxy]butanedioic acid
(2r)-2-[4-(3,4-dihydroxyphenyl)-6,7-dihydroxynaphthalene-2-carbonyloxy]butanedioic acid
(2s,3s,6r,8s)-4-chloro-3-ethenyl-8-hydroxy-2-isothiocyanato-3,7,7,10-tetramethyl-10-azatetracyclo[6.6.1.1²,⁶.0¹¹,¹⁵]hexadeca-1(14),4,11(15),12-tetraene-9,16-dione
3-carboxy-6,7-dihydroxy-1-(3',4'-dihydroxy-phenyl)-naphthalene-9,2''-o-malicacid ester
{"Ingredient_id": "HBIN008377","Ingredient_name": "3-carboxy-6,7-dihydroxy-1-(3',4'-dihydroxy-phenyl)-naphthalene-9,2''-o-malicacid ester","Alias": "NA","Ingredient_formula": "C21H16O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3167","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4-chloro-3-ethenyl-8-hydroxy-2-isothiocyanato-3,7,7,10-tetramethyl-10-azatetracyclo[6.6.1.1²,⁶.0¹¹,¹⁵]hexadeca-1(14),4,11(15),12-tetraene-9,16-dione
(1s,4ar,4bs,8s,8as,10as)-1-bromo-8a-(bromomethyl)-8-isopropyl-10a-methyl-4-methylidene-2,3,4a,4b,7,8,9,10-octahydro-1h-phenanthrene
1,2,3,4,5-pentahydroxy-8-(methanesulfonylmethyl)-7-methoxy-2-methyl-3,4-dihydro-1h-anthracene-9,10-dione
4-(benzylsulfanyl)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol
C22H20O7S (428.09296900000004)
(4s,5r,6s)-4,5-dihydroxy-6-{[5-hydroxy-3-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy}-5,6-dihydro-4h-pyran-2-carboxylic acid
3-[7-methyl-6,8-dioxo-7-(3,4,6-trihydroxy-2-methylbenzoyloxy)isochromen-3-yl]prop-2-enoic acid
7-{[(1s,3s,4r,5s,8r)-4,8-dihydroxy-7-oxo-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy}-5,6-dihydroxy-2-phenylchromen-4-one
(1r,2s,3r,4s)-1,2,3,4,5-pentahydroxy-8-(methanesulfonylmethyl)-7-methoxy-2-methyl-3,4-dihydro-1h-anthracene-9,10-dione
(1r,4s,5s,12r)-2,13-dioxo-8-oxa-22,23-dithia-3,14-diazahexacyclo[10.9.2.0¹,¹⁴.0³,¹².0⁴,¹⁰.0¹⁵,²⁰]tricosa-6,9,15,17,19-pentaen-5-yl acetate
7-({4,8-dihydroxy-7-oxo-2,6-dioxabicyclo[3.2.1]octan-3-yl}oxy)-5,6-dihydroxy-2-phenylchromen-4-one
(1s,4bs,8s,8as,10as)-1-bromo-8a-(bromomethyl)-8-isopropyl-4,10a-dimethyl-1,2,3,4b,7,8,9,10-octahydrophenanthrene
3-acetyl-2,7-dihydroxy-1-methoxy-4,6,11-trioxo-4a,12-dihydro-1h-5-oxatetracene-12a-carboxylic acid
3-[(7r)-7-methyl-6,8-dioxo-7-(3,4,6-trihydroxy-2-methylbenzoyloxy)isochromen-3-yl]prop-2-enoic acid
2,13-dioxo-8-oxa-22,23-dithia-3,14-diazahexacyclo[10.9.2.0¹,¹⁴.0³,¹².0⁴,¹⁰.0¹⁵,²⁰]tricosa-6,9,15,17,19-pentaen-5-yl acetate
(2r,3s,4s)-4-(benzylsulfanyl)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol
C22H20O7S (428.09296900000004)